32738031|t|Protective effects of isoquercitrin on streptozotocin-induced neurotoxicity.
32738031|a|Alzheimer's disease (AD) is characterized by irreversible and progressive memory loss and has no effective treatment. Recently, many small molecule nature products have been identified with neuroprotective functions and shown beneficial effects to AD patients. In the current study, we thus performed a small scale screening to determine the protective effects of natural compounds on streptozotocin (STZ)-induced neurotoxicity and Alzheimer's disease (AD). We found that a lead flavonoid compound, isoquercitrin (ISO) display the most effective anti-cytotoxic activities via inhibiting STZ-induced apoptosis, mitochondria dysfunction and oxidative stress. Treatment with ISO largely rescues STZ-induced differentiation inhibition and enhances neurite outgrowth of Neuro2a (N2a) cells in vitro. Moreover, oral administration of ISO protects hippocampal neurons from STZ-induced neurotoxicity and significantly improves the cognitive and behavioural impairment in STZ-induced AD rats. In general, our screening identifies ISO as an effective therapeutic candidate against STZ-induced neurotoxicity and AD-like changes.
32738031	22	35	isoquercitrin	Chemical	MESH:C016527
32738031	39	53	streptozotocin	Chemical	MESH:D013311
32738031	62	75	neurotoxicity	Disease	MESH:D020258
32738031	77	96	Alzheimer's disease	Disease	MESH:D000544
32738031	98	100	AD	Disease	MESH:D000544
32738031	151	162	memory loss	Disease	MESH:D008569
32738031	325	327	AD	Disease	MESH:D000544
32738031	328	336	patients	Species	9606
32738031	462	476	streptozotocin	Chemical	MESH:D013311
32738031	478	481	STZ	Chemical	MESH:D013311
32738031	491	504	neurotoxicity	Disease	MESH:D020258
32738031	509	528	Alzheimer's disease	Disease	MESH:D000544
32738031	530	532	AD	Disease	MESH:D000544
32738031	556	565	flavonoid	Chemical	MESH:D005419
32738031	576	589	isoquercitrin	Chemical	MESH:C016527
32738031	591	594	ISO	Chemical	MESH:C016527
32738031	664	667	STZ	Chemical	MESH:D013311
32738031	687	711	mitochondria dysfunction	Disease	MESH:C564971
32738031	749	752	ISO	Chemical	MESH:C016527
32738031	769	772	STZ	Chemical	MESH:D013311
32738031	842	849	Neuro2a	CellLine	CVCL:0470
32738031	851	854	N2a	CellLine	CVCL:0470
32738031	905	908	ISO	Chemical	MESH:C016527
32738031	943	946	STZ	Chemical	MESH:D013311
32738031	955	968	neurotoxicity	Disease	MESH:D020258
32738031	1000	1036	cognitive and behavioural impairment	Disease	MESH:D003072
32738031	1040	1043	STZ	Chemical	MESH:D013311
32738031	1052	1054	AD	Disease	MESH:D000544
32738031	1055	1059	rats	Species	10116
32738031	1098	1101	ISO	Chemical	MESH:C016527
32738031	1148	1151	STZ	Chemical	MESH:D013311
32738031	1160	1173	neurotoxicity	Disease	MESH:D020258
32738031	1178	1180	AD	Disease	MESH:D000544
32738031	Negative_Correlation	MESH:C016527	MESH:D020258
32738031	Negative_Correlation	MESH:C016527	MESH:D013311
32738031	Positive_Correlation	MESH:D013311	MESH:C564971
32738031	Negative_Correlation	MESH:D005419	MESH:D013311
32738031	Negative_Correlation	MESH:D005419	MESH:C564971
32738031	Negative_Correlation	MESH:C016527	MESH:D000544
32738031	Negative_Correlation	MESH:C016527	MESH:C564971
32738031	Positive_Correlation	MESH:D013311	MESH:D020258
32738031	Positive_Correlation	MESH:C016527	MESH:D003072

